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Eating a healthy diet is important for managing diabetes. Although there are high rates of diabetes in low-income
urban areas, these patients often have limited access to fruits and vegetables. The 15-week Fresh Prescription
(Fresh Rx) program was designed to improve access and consumption of fruits and vegetables among low-income
patients with diabetes in Detroit, MI. The purpose of this study was to evaluate the effects of a fruit and vegetable
prescription program on changes in hemoglobin A1C (HbA1C), blood pressure (BP), and body mass index (BMI)
in patients with diabetes in a randomized controlled trial at a federally qualified health center (FQHC). Patients
randomized to the Fresh Rx group (n = 56) were allotted up to $80 ($10 for up to eight weeks) for purchase of
produce from a farmers market based at the FQHC. The control group (n = 56) received standard treatment plus
information on community resources to improve health. Outcomes were compared at baseline and within three
months of program completion. There were no significant between-group differences for any of the outcomes at
program completion (p > .05); however, there was a small effect size for HbA1c (partial η2 = 0.02).
Within the Fresh Rx group, HbA1c significantly decreased from 9.64% to 9.14% (p = 0.006). However, no
changes were noted within the control group (9.38 to 9.41%, p = 0.89). BMI and BP did not change from pre- to
post-study in either group (p > .05). Results from this study offer preliminary evidence that produce prescription
programs may reduce HbA1C in low-income patients with diabetes.

1. Introduction
Diabetes is a serious chronic disease that affects the health of millions
of people across the world. Unfortunately, the prevalence of diabetes
continues to grow. The Global Burden of Disease report from 2015,

showed that the prevalence of diabetes worldwide increased from 333
million persons in 2005 to 435 million persons in 2015 (GBD 2015
Disease and Injury Incidence and Prevalence Collaborators, 2016). Over
that same time the prevalence of diabetes in the United States increased
from 16.5 million persons in 2005 to 23.4 million persons in 2015

Abbreviations: BP, blood pressure (mmHg); BMI, body mass index; Fresh Rx, Fresh Prescription Program; FQHC, Federally Qualified Health Center; HbA1C,
hemoglobin A1c concentration (percent.
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(Division of Diabetes Translation and Centers for Disease Control and
Prevention, 2017). The rate of increase of diabetes is higher among
racial and ethnic minorities (Ingelfinger and Jarcho, 2017) especially
those living in poverty (Agardh et al., 2011). One reason for this
disparity can be related to diet (Agardh et al., 2011). In 2018, at least
14.3 million American households were experiencing food insecurity
(Agardh et al., 2011). Those experiencing food insecurity are unable to
afford balanced meals and may cut back on the size of meals or go
hungry because of too little money for food (Agardh et al., 2011).
Households near or below the federal poverty line, and Black and His
panic headed households are most affected by food insecurity (ColemanJensen et al., 2017). Low-income households are less likely to consume
the recommended amount of fruits and vegetables (Grimm et al., 2012).
Increasing fruit and vegetable intake has been shown to decrease the
risk of developing type 2 diabetes and is also beneficial in the treatment
of type 2 diabetes (Ford and Mokdad, 2001). Fruit and vegetable pre
scription programs (sometimes called produce prescription programs)
can be an effective way to encourage an increase in fruit and vegetable
consumption in those living from poverty (Forbes et al., 2019; Freedman
et al., 2013; Marcinkevage et al., 2019; Omar et al., 2017; Trapl et al.,
2018; Weinstein et al., 2014). This incentive model typically allows a
health care provider to “prescribe” fresh fruit and vegetables to patients
experiencing diet-related chronic diseases while receiving nutrition
education in a clinical setting. Fruit and vegetable prescription programs
have been shown to encourage healthy eating habits (Aiyer et al., 2019;
Cavanagh et al., 2017; Forbes et al., 2019; Freedman et al., 2013;
Marcinkevage et al., 2019; Omar et al., 2017; Richie, 2019; Ridberg
et al., 2019; Saxe-Custack et al., 2019; Snailer, 2019; Trapl et al., 2018;
Weinstein et al., 2014; York et al., 2020), decrease the prevalence of
food insecurity (Aiyer et al., 2019), and have been associated with an
increase in fruit and vegetable consumption in both adults (Forbes et al.,
2019; Freedman et al., 2013; Marcinkevage et al., 2019; Omar et al.,
2017; Trapl et al., 2018; Weinstein et al., 2014) and children (Ridberg
et al., 2019; Saxe-Custack et al., 2019). The 2018 Farm Bill authorized
the Gus Schumacher Nutrition Incentive Program (GusNIP), which
provides funding opportunities to conduct and evaluate fruit and
vegetable prescription programs by low-income consumers.
Limited research to date has examined clinical outcomes related to
fruit and vegetable prescription programs; all have been single group,
pre/post-program analyses (Forbes et al., 2019; Freedman et al., 2013;
Marcinkevage et al., 2019; Omar et al., 2017; Trapl et al., 2018; Wein
stein et al., 2014). These studies have demonstrated a significant
decrease in body mass index (BMI) (Cavanagh et al., 2017) and blood
pressure (BP) (York et al., 2020), as well as improvement in blood
glucose control (Richie, 2019; Snailer, 2019). A 2015 study of patients
with type 2 diabetes participating in a fruit and vegetable prescription
program found participants experienced a significant decrease in he
moglobin A1C percentage (HbA1C) (i.e., 9.54 to 8.83) (Bryce et al.,
2017). However, weight and BP did not change from pre- to post-study
(p > .05) (Bryce et al., 2017). Although these results are encouraging,
more rigorous investigation (i.e., inclusion of a comparison group and
randomization of participants) is needed to strengthen the degree of
evidence of the impact of fruit and vegetable prescription programs.
To fill this gap, the goal of this study was to complete a pilot ran
domized controlled trial of patients with type 2 diabetes participating in
a fruit and vegetable prescription program. We assessed changes in
HbA1C, BP, and BMI to discern the impact on those that participated in a
fruit and vegetable prescription program compared to those that
received non-incentivized diabetes standard of care.

food system. This fosters innovative relationships to enhance the un
derstanding of the correlation between food choices and health, increase
consumption of locally grown fruits and vegetables, and build a healthy
sustainable food system. This promising approach to a healthier food
system connects patients to fresh, locally grown produce while
providing direct economic benefits to small and midsize farmers and
improving health and quality of life for participants.
We conducted a pilot randomized controlled trial from June 1, 2018
through January 1, 2019 to test the effects of the Fresh Rx program on
patients from a Federally Qualified Health Center (FQHC) in Detroit, MI.
The majority of patients from this FQHC are of lower socioeconomic
status, which reflects a typical urban FQHC in the United States (Na
tional Association of Community Health Centers, 2020). The design of
this trial used the principals of community based participatory research
to guide this investigation (Israel et al., 2010, 2005). A community
advisory board was created with a mixture of academic and community
partners to best evaluate the program and research process. This study
was approved by the Institutional Review Board of the Henry Ford
Health System.
The Fresh Rx program allotted up to $80 ($10 per visit for up to 8
visits) for purchase of fresh fruits and vegetables at that FQHC’s farmers’
market (referred to as the Mercado). The Mercado, which is located
outside the entrance to the health center, is a collection of several local
produce farmers. The Mercado operated every Thursday (9 AM to 1 PM)
and occurred over 15 weeks from June 2018 to October 2018. In addi
tion to selling fresh produce, the Mercado also offers many other positive
health promoting activities including cooking demonstrations, nutrition
education and exercise events.
Fresh Rx participants were able fill their prescription at the Mercado
for fresh produce up to 8 times during the 15-week Fresh Rx program.
The visits could but did not necessarily need to be in consecutive weeks.
The provided debit cards were loaded with the $10 stipend at each visit.
The participants, as well as farmers at the Mercado, were educated about
the program and signage at vendor booths reinforced eligible purchases,
which included only fresh produce. Prepared foods and juices, even if
they were fruit or vegetable based, were not an eligible purchase. At
each market session, cooking demonstrations took place that reinforced
healthy food options and how to prepare foods that were available at the
Mercado. Participants could return to the Mercado at other times after
the completion of their 8 visits but did not receive any further financial
incentives.
2.2. Study participants
A list was generated from the electronic medical records of the
FQHC, of all non-pregnant patients with type 2 diabetes who had a
HbA1C > 8.0% over the 6 months prior to the start of the Fresh Rx
Program (N = 530). Using simple randomization, the list was random
ized into two groups: the intervention group and the control group. (n =
265 each group). The randomization occurred prior to enrollment to
decrease the work burden of program coordination for both the Fresh Rx
program and the subsequent research. Those selected for the interven
tion group and the control group were contacted by telephone and
offered participation by a community health worker (CHW). Both the
CHWs and potential participants were aware of which group they were
randomized (intervention vs. control) prior to participation. Once
agreeable to participate, both groups were brought into the center to
sign an informed consent. At that time, they had their BP, weight and
HbA1C measured.
All Fresh Rx participants completed a basic program orientation that
included receiving their Fresh Rx debit card that could be used with
Mercado vendors. All participants then had their BP, weight and HbA1C
checked inside the FQHC after their last visit to the Mercado or within 3
months of the completion of the Fresh Rx program (January 1, 2019).
The 3-month time period for follow up was chosen understanding the
HbA1C test shows the average amount of glucose attached to

2. Methods
2.1. Program
The Fresh Prescription (Fresh Rx) Program is a fruit and vegetable
prescription program that brings together the healthcare system and the
2
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hemoglobin has been over the previous 3 months (MedlinePlus, 2020).
All control group participants were given flyers describing all the
health and wellness programs at the FQHC including the Mercado. This
information is the standard of care that is shared with all of the patients
with type 2 diabetes at the Detroit based FQHC. No incentive was given
for the Mercado. Control group participants were then given a $10 gift
card to a national brand pharmacy (no fresh produce available). The
enrollment time for the control group overlapped the Fresh Rx group
(June to September 2018). After a 3-month time period, control group
participants returned and had a repeat BP, weight and HbA1C measured.
They then were given a $20 gift card to the same national brand
pharmacy.

number of times participants utilized the market. Chi-squared analyses
and independent samples t-tests were conducted to determine whether
there were any demographic or biometric data differences between the
intervention and control groups at baseline. Analysis of covariances
(ANCOVA) were also conducted to examine whether there were signif
icant differences in HbA1C, BMI, and systolic and diastolic blood pres
sure readings between groups, controlling for baseline levels. Paired
sample t-tests were conducted from pre- to post-program to evaluate
changes in HbA1C, BMI, and systolic and diastolic blood pressure
readings within the intervention and control groups. We also ran ana
lyses using an intent-to-treat approach, such that we used baseline
biometric data as the follow-up numbers for those who were lost to
follow-up. Using this approach, we had similar results, and so we chose
to present the data from those who completed the follow-up for ease of
interpretation. All analyses were performed using SPSS version 25 (IBM,
Armonk, NY) and statistical significance was considered at p < .05.
Partial eta effect sizes were reported for ANCOVA analyses, with

2.3. Statistical analyses
Descriptive analyses were conducted to determine the percentages,
means, and standard deviations of participant demographics and the

Fig. 1. Flow of Participants through the Study.
3
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interpretation as 0.01, 0.09, and 0.25 being small, medium, and large,
respectively. Cohen’s d effect sizes were reported for paired samples ttests and included the correlation of the pre- and post-intervention
variables in the calculation. Interpretation was small (0.2), medium
(0.5), or large (0.8).

Table 2
Number of visits to Mercado throughout the 15-week Fresh Rx program (n =
56).

3. Results
Of the 265 adult, non-pregnant, patients with type 2 diabetes who
were randomized to the intervention program and the control group,
23.8% (n = 63) and 24.5% (n = 65) agreed to participate, respectively
(Fig. 1). There were 56 participants in the control group and 56 par
ticipants in the intervention group who had both baseline and follow-up
data and were included in the final analyses. Characteristics of study
participants are in Table 1. For both the intervention and control group,
most participants were female, Latinx, and were either uninsured or
underinsured. There were no significant differences between interven
tion and control groups for demographics or baseline HbA1c, BMI, or BP
(Table 1). More than half of intervention participants had at least 5
market visits (58.9%, n = 33) during the 15-week program, and more
than a quarter went to the Mercado at least 8 times and used all 8 pre
scriptions (28.6%, n = 16) (Table 2).
There were no significant differences between the control and
intervention groups for any of the outcome variables (i.e., BMI, BP, or
HbA1c) following the intervention; however, there was a small effect
size for HbA1c (Table 3).
Because this was a pilot trial, we conducted within group analyses (i.
e., intervention and control groups) to determine whether there was a
signal to indicate a potential change from pre- to post-intervention
(Table 3). Within the Fresh Rx group, HbA1C significantly decreased,
with a small to medium effect size, while no changes were noted within
the control group (Fig. 2 and Table 3). BMI and BP did not change from
pre- to post-study in either group (p > .05).

The findings from this pilot randomized control trial of a fruit and
vegetable prescription program in a FQHC, suggest that such a program
may assist in the management of HbA1C among patients with type 2
diabetes. This supports previous research that suggested this type of
Table 1
Patient Demographics.
Control
n = 56

Characteristics

n

%

n

%

X2

p

Gender
Female
Male

41
15

73.2
26.8

33
23

58.9
41.1

2.55

0.11

Race/Ethnicity
Hispanic or Latino
Black/African American
White/Caucasian

41
12
3

73.2
21.4
5.3

37
17
2

66.1
30.4
3.6

1.27

0.53

Insurance status
No insurance
Medicaid/Medicare
Commercial insurance

23
25
8

41.1
44.6
14.3

20
31
5

35.7
55.4
8.9

1.54

0.46

M

SD

M

SD

t

p

54.2
9.69
32.98
131.11
78.98

10.5
2.10
6.67
17.57
8.88

53.4
9.38
34.49
132.32
79.02

11.9
1.99
8.14
17.61
9.20

− 0.37
− 0.81
1.07
0.37
0.02

0.71
0.42
0.26
0.72
0.98

Age, years
Baseline HbA1C
Baseline BMI
Baseline SBP
Baseline DBP

n

%

8
7
6
5
4
3
2
1

16
5
5
7
4
3
4
12

28.6
8.9
8.9
12.5
7.1
5.4
7.1
21.4

program may be useful for patients with type 2 diabetes (Bryce et al.,
2017) and demonstrates that findings hold when including a
comparison.
Fresh prescription programs may be effective as they give access of
fresh produce to those that may have limitations due to food insecurity
or live in food deserts (Hennessee, 2020). In more impoverished areas,
many have limited ability to purchase fruits and vegetables due to cost
or limited availability in stores selling fresh produce in their neighbor
hoods. These challenges can often lead to a poor diet (Swartz, 2018).
When incentivizing people to eat more fruits and vegetables, they may
be more likely to eat less junk food and consume healthier food. Also,
they encourage participants to make the connection between nutrition
and health (Boone-Heinonen et al., 2011). Thus, it is possible that the
benefits could extend beyond the fruit and vegetable prescription pro
gram; however, future research is needed to examine longer term out
comes. Results from the evaluations of fruit and vegetable prescription
programs have shown that participants consume more fruits and vege
tables (Forbes et al., 2019; Freedman et al., 2013; Marcinkevage et al.,
2019; Omar et al., 2017; Trapl et al., 2018; Weinstein et al., 2014). They
also have demonstrated improved health outcomes in weight, hyper
tension and diabetes (Cavanagh et al., 2017; Richie, 2019; Snailer, 2019;
York et al., 2020). The results of this pilot randomized controlled trial
strengthen the evidence of the positive impact of fruit and vegetable
prescription programs on FQHC patients with type 2 diabetes.
We did not see a change in BMI or BP in either the intervention group
or the control group. From our data, it is unclear if weight and blood
pressure are likely to respond positively to fruit and vegetable pre
scription programs. This has been shown in other studies (Ford and
Mokdad, 2001) and although patient demographics and study time
lengths are similar, all the studies including this one, have limited
sample sizes. Also, we chose a 3-month follow-up window for partici
pants as that corresponds best for the possible influence on the HbA1C
test (MedlinePlus, 2020). The follow-up timeline of our study may have
contributed to the lack of change in BMI and BP.
There are several strengths of this study that add to the current
literature on fruit and vegetable prescription programs, including hav
ing a control group and having high retention rates across the inter
vention and control groups. Despite this, there are also some limitations
that should be noted. First, the smaller than anticipated sample size
likely prevented us from finding a significant between-group effect,
given that the effect size was small. Increasing the sample size in a fully
powered randomized control trial will allow us to better understand the
significance of the pre- and post-biometric data. Second, randomization
was conducted before entry into the study. This could have introduced
bias and affected the statistical equivalence as CHWs and participants
were aware of to which group they were randomized. Future research
should conduct randomization into conditions after enrollment in the
study.
One challenge we saw in the Fresh Rx program is many of those
offered participation elected not to participate. Further, of those that
were in the Fresh Rx group, there were varying levels of Mercado visits,
with approximately 20% only attending once. This suggests that there
may be barriers to participation in this program. Future research should

4. Discussion

Fresh Rx
n = 56

Number of Visits

BMI, body mass index; DBP, diastolic blood pressure; ES, Effect Size; HbA1C,
hemoglobin A1C percentage; M, Mean; SBP, systolic blood pressure.
4
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Table 3
Weight, Blood Pressure and Hemoglobin A1C.
Fresh Rx Intervention Group (n = 56)

BMI
Systolic BP (mm
Hg)
Diastolic BP (mm
Hg)
HbA1C (%)

Control Group (n = 56)
a

a

PreIntervention
M (SD)

PostIntervention
M (SD)

ta

pa

ESb

Fc

pc

0.10
0.06

34.39 (8.14)
132.32 (17.61)

34.51 (8.05)
134.00 (19.17)

− 0.11
− 0.80

0.91
0.43

0.11
0.11

0.24
1.19

0.63
0.28

0.002
0.01

0.47

0.10

79.02 (9.20)

78.32 (8.33)

0.67

0.51

0.09

0.003

0.96

<0.001

0.006

0.38

9.38 (1.99)

9.41 (1.95)

− 0.14

0.89

0.02

2.63

0.11

0.02

PreIntervention
M (SD)

PostIntervention
M (SD)

t

p

32.98 (6.67)
131.11 (17.57)

33.26 (6.68)
130.21 (17.53)

− 0.75
0.42

0.46
0.68

78.98 (8.88)

78.23 (8.02)

0.72

9.69 (2.10)

9.15 (1.78)

2.86

ES

b

ESd

BMI, body mass index; BP, blood pressure; ES, Effect Size; HbA1C, hemoglobin A1C; M, Mean; SD, Standard Deviation.
a
Within-group paired samples t-test.
b

Cohen’s d effect sizes.

c

Between-group ANCOVA, controlling for baseline levels.

d

Partial eta squared effect sizes.
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Fig. 2. Hemoglobin A1C (HbA1C) Pre- and Post-Fresh Rx Intervention.

evaluate barriers to implementation and methods in which to improve
interest in participation, which could include increasing the hours of the
market, expanding the length of the market season, expanding the
stores/locations at which the benefit can be spent, and delivering the
fresh produce to those that have challenges with transportation. It also
would be important to examine fruit and vegetable prescription pro
grams on different patient populations including those from more sub
urban or rural areas, those that reflect different races and ethnicities, as
well as those with different socioeconomic status.
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5. Conclusion
The findings of this study demonstrate the potential impact of fruit
and vegetable prescription programs on the health of patients with type
2 diabetes. Future research should evaluate this type of program in a
fully powered randomized controlled trial to examine efficacy and po
tential mechanisms of change. If these programs are found to be effi
cacious for improving HbA1C among patients with type 2 diabetes and
low income/socioeconomic status, insurance companies may want to
consider implementing routine fruit and vegetable prescriptions as a
part of health care plans to improve patient health and the economic
impact of type 2 diabetes.

References
Agardh, E., Allebeck, P., Hallqvist, J., Moradi, T., Sidorchuk, A., 2011. Type 2 diabetes
incidence and socio-economic position: a systematic review and meta-analysis. Int. J.
Epidemiol. 40 (3), 804–818. https://doi.org/10.1093/ije/dyr029.
Aiyer, J.N., Raber, M., Bello, R.S., Brewster, A., Caballero, E., Chennisi, C., Durand, C.,
Galindez, M., Oestman, K., et al., 2019. A pilot food prescription program promotes
produce intake and decreases food insecurity. Transl. Behav. Med. 9 (5), 922–930.
https://doi.org/10.1093/tbm/ibz112.
Boone-Heinonen, J., Gordon-Larsen, P., Kiefe, C.I., Shikany, J.M., Lewis, C.E., Popkin, B.
M., 2011. Fast food restaurants and food stores: longitudinal associations with diet in
young to middle-aged adults: the CARDIA study. Arch. Intern. Med. 171 (13),
1162–1170. https://doi.org/10.1001/archinternmed.2011.283.
Bryce, R., Guajardo, C., Ilarraza, D., Milgrom, N., Pike, D., Savoie, K., Valbuena, F.,
Miller-Matero, L.R., 2017. Participation in a farmers’ market fruit and vegetable
prescription program at a federally qualified health center improves hemoglobin

Funding
This work was supported by Blue Cross Blue Shield Foundation of
Michigan, [grant number 002461.MG]
5

R. Bryce et al.

Preventive Medicine Reports 23 (2021) 101410
Israel, B.A., Eng, E., Schulz, A.J., Parker, E.A., 2005. Methods in community-based
participatory research for health. Jossey-Bass, San Francisco, CA.
Marcinkevage, J., Auvinen, A., Nambuthiri, S., 2019. Washington State’s fruit and
vegetable prescription program: improving affordability of healthy foods for lowincome patients. Prev. Chronic Dis. 16, E91. https://doi.org/10.5888/
pcd16.180617.
MedlinePlus, 2020. Hemoglobin A1C (HbA1c) test. ’Available from’: https://med
lineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/.
National Association of Community Health Centers, 2020. Key health center data by
state, 2020 federally-funded health centers only. ’Available from’: https://www.
nachc.org/wp-content/uploads/2020/09/2020-Key-Facts-by-State.pdf.
Omar, J., Heidemann, D.L., Blum-Alexandar, B., Uku-Eke, C., Alam, Z., Willens, D.E.,
Wisdom, K., 2017. Fresh prescirption: improving nutrition education and access to
fresh produce in Detroit [abstract]. J. Gen. Intern. Med. 32 (2 Suppl.), S752.
Richie, K.A., 2019. The impact of a fruit and vegetable farmer’s market voucher
prescription program on a low-income rural population [master’s thesis]. University
of Kentucky, Lexington, KY.
Ridberg, R.A., Bell, J.F., Merritt, K.E., Harris, D.M., Young, H.M., Tancredi, D.J., 2019.
Effect of a fruit and vegetable prescription program on children’s fruit and vegetable
consumption. Prev. Chronic Dis. 16, E73. https://doi.org/10.5888/pcd16.180555.
Saxe-Custack, A., LaChance, J., Hanna-Attisha, M., 2019. Child consumption of whole
fruit and fruit juice following six months of exposure to a pediatric fruit and
vegetable prescription program. Nutrients 12 (1), 25. https://doi.org/10.3390/
nu12010025.
Snailer, B., 2019. Lowering HbA1c in food insecure type 2 diabetics through a fruit and
vegetable prescription program [master’s thesis]. University of Washington, Seattle,
WA.
Swartz, H., 2018. Produce Rx programs for diet-based chronic disease prevention. AMA
J. Ethics 20 (10), E960–E973. https://doi.org/10.1001/amajethics.2018.960.
Trapl, E.S., Smith, S., Joshi, K., Osborne, A., Benko, M., Matos, A.T., Bolen, S., 2018.
Dietary impact of produce prescriptions for patients with hypertension. Prev.
Chronic Dis. 15, E138. https://doi.org/10.5888/pcd15.180301.
Weinstein, E., Galindo, R.J., Fried, M., Rucker, L., Davis, N.J., 2014. Impact of a focused
nutrition educational intervention coupled with improved access to fresh produce on
purchasing behavior and consumption of fruits and vegetables in overweight
patients with diabetes mellitus. Diabetes Educ. 40 (1), 100–106. https://doi.org/
10.1177/0145721713508823.
York, B., Kujan, M., Conneely, C., Glantz, N., Kerr, D., 2020. Farming for life: pilot
assessment of the impact of medical prescriptions for vegetables on health and food
security among Latino adults with type 2 diabetes. Nutr. Health 26 (1), 9–12.
https://doi.org/10.1177/0260106019898995.

A1C in low income uncontrolled diabetics. Prev. Med. Rep. 7, 176–179. https://doi.
org/10.1016/j.pmedr.2017.06.006.
Cavanagh, M., Jurkowski, J., Bozlak, C., Hastings, J., Klein, A., 2017. Veggie Rx: an
outcome evaluation of a healthy food incentive programme. Public Health Nutr. 20
(14), 2636–2641. https://doi.org/10.1017/S1368980016002081.
Coleman-Jensen, A., Rabbitt, M.P., Gregory, C.A., Singh, A., 2017. Household food
security in the United States in 2016 (Economic Research Report No. 237). United
States Department of Agriculture, Washington, DC.
Division of Diabetes Translation, Centers for Disease Control Prevention, 2017. Longterm trends in diabetes. ’Available from’: https://www.cdc.gov/DIABETES/statistic
s/slides/long_term_trends.pdf.
Forbes, J.M., Forbes, C.R., Lehman, E., George, D.R., 2019. “Prevention Produce”:
integrating medical student mentorship into a fruit and vegetable prescription
program for at-risk patients. Perm J. 23, 18–238. https://doi.org/10.7812/TPP/18238.
Ford, E.S., Mokdad, A.H., 2001. Fruit and vegetable consumption and diabetes mellitus
incidence among U.S. adults. Prev. Med. 32 (1), 33–39. https://doi.org/10.1006/
pmed.2000.0772.
Freedman, D.A., Choi, S.K., Hurley, T., Anadu, E., Hebert, J.R., 2013. A farmers’ market
at a federally qualified health center improves fruit and vegetable intake among lowincome diabetics. Prev. Med. 56 (5), 288–292. https://doi.org/10.1016/j.
ypmed.2013.01.018.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, 2016. Global,
regional, and national incidence, prevalence, and years lived with disability for 310
diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of
Disease Study 2015. Lancet 388 (10053), 1545–1602. https://doi.
org/10.1016/S0140-6736(16)31678-6.
Grimm, K.A., Foltz, J.L., Blanck, H.M., Scanlon, K.S., 2012. Household income disparities
in fruit and vegetable consumption by state and territory: results of the 2009
Behavioral Risk Factor Surveillance System. J. Acad. Nutr. Diet. 112 (12),
2014–2021. https://doi.org/10.1016/j.jand.2012.08.030.
Hennessee, E., 2020. Veggie Rx in the 2018 Farm Bill. ’Available from’: https://clf.jhsph.
edu/sites/default/files/2020-04/veggie-rx-in-the-2018-farm-bill.pdf.
Ingelfinger, J.R., Jarcho, J.A., 2017. Increase in the incidence of diabetes and its
implications. N. Engl. J. Med. 376 (15), 1473–1474. https://doi.org/10.1056/
NEJMe1616575.
Israel, B.A., Coombe, C.M., Cheezum, R.R., Schulz, A.J., McGranaghan, R.J.,
Lichtenstein, R., Reyes, A.G., Clement, J., Burris, A., 2010. Community-based
participatory research: a capacity-building approach for policy advocacy aimed at
eliminating health disparities. Am. J. Public Health 100 (11), 2094–2102. https://
doi.org/10.2105/AJPH.2009.170506.

6

